{"transactions":[{"id":1808779,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":110573,"kind":"person","name":"Smith Sean Michael","position":1,"cik":"0001914769","reported_name":"Smith Sean Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO, Prin Acct Off"}}],"security":"Restricted Stock Units","published_at":"2023-08-14T16:06:55.000Z","date":"2023-08-10","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs will vest as to 1/2 of the total number of shares underlying the award on each of August 10, 2022 and August 10, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs do not expire; these securities either vest and settle or are canceled prior to the vesting date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-23-045611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1914769/000120919123045611/doc4.xml","form_type":"4"}},{"id":1808778,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":110573,"kind":"person","name":"Smith Sean Michael","position":1,"cik":"0001914769","reported_name":"Smith Sean Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO, Prin Acct Off"}}],"security":"Common Stock","published_at":"2023-08-14T16:06:55.000Z","date":"2023-08-11","kind":"sale","planned":false,"acquired":false,"shares":1323,"price":0.6184,"value":818.1432,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $.6146 and the highest price at which shares were sold was $0.6399. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,000 shares of common stock acquired by the Reporting Person on May 15, 2023 pursuant to the Issuer's employee stock purchase plan."}],"balance_after":21637,"source":{"system":"sec-edgar","filing":"0001209191-23-045611","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1914769/000120919123045611/doc4.xml","form_type":"4"}},{"id":1808777,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":110573,"kind":"person","name":"Smith Sean Michael","position":1,"cik":"0001914769","reported_name":"Smith Sean Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO, Prin Acct Off"}}],"security":"Common Stock","published_at":"2023-08-14T16:06:55.000Z","date":"2023-08-10","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,000 shares of common stock acquired by the Reporting Person on May 15, 2023 pursuant to the Issuer's employee stock purchase plan."}],"balance_after":22960,"source":{"system":"sec-edgar","filing":"0001209191-23-045611","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1914769/000120919123045611/doc4.xml","form_type":"4"}},{"id":2033500,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":110573,"kind":"person","name":"Smith Sean Michael","position":1,"cik":"0001914769","reported_name":"Smith Sean Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-03T16:33:55.000Z","date":"2023-02-01","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs will vest as to 1/2 of the total number of shares underlying the award on each of February 1, 2023 and February 1, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs do not expire; these securities either vest and settle or are canceled prior to the vesting date."}],"balance_after":12500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-23-006886","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1914769/000120919123006886/doc4.xml","form_type":"4"}},{"id":2033499,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":110573,"kind":"person","name":"Smith Sean Michael","position":1,"cik":"0001914769","reported_name":"Smith Sean Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2023-02-03T16:33:55.000Z","date":"2023-02-02","kind":"sale","acquired":false,"shares":3316,"price":0.5972,"value":1980.3152,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $0.576 and the highest price at which shares were sold was $0.635. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":15960,"source":{"system":"sec-edgar","filing":"0001209191-23-006886","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1914769/000120919123006886/doc4.xml","form_type":"4"}},{"id":2033498,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":110573,"kind":"person","name":"Smith Sean Michael","position":1,"cik":"0001914769","reported_name":"Smith Sean Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2023-02-03T16:33:55.000Z","date":"2023-02-01","kind":"exercise","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19276,"source":{"system":"sec-edgar","filing":"0001209191-23-006886","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1914769/000120919123006886/doc4.xml","form_type":"4"}},{"id":2187154,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":110573,"kind":"person","name":"Smith Sean Michael","position":1,"cik":"0001914769","reported_name":"Smith Sean Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2022-08-12T17:24:42.000Z","date":"2022-08-10","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs will vest as to 1/2 of the total number of shares underlying the award on each of August 10, 2022 and August 10, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs do not expire; these securities either vest and settle or are canceled prior to the vesting date."}],"balance_after":5000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-22-045667","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1914769/000120919122045667/doc4.xml","form_type":"4"}},{"id":2187153,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":110573,"kind":"person","name":"Smith Sean Michael","position":1,"cik":"0001914769","reported_name":"Smith Sean Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2022-08-12T17:24:42.000Z","date":"2022-08-10","kind":"sale","acquired":false,"shares":1655,"price":0.9914,"value":1640.767,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $.9801 and the highest price at which shares were sold was $1.01. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":6776,"source":{"system":"sec-edgar","filing":"0001209191-22-045667","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1914769/000120919122045667/doc4.xml","form_type":"4"}},{"id":2187152,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":110573,"kind":"person","name":"Smith Sean Michael","position":1,"cik":"0001914769","reported_name":"Smith Sean Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2022-08-12T17:24:42.000Z","date":"2022-08-10","kind":"exercise","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8431,"source":{"system":"sec-edgar","filing":"0001209191-22-045667","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1914769/000120919122045667/doc4.xml","form_type":"4"}},{"id":2194675,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":110573,"kind":"person","name":"Smith Sean Michael","position":1,"cik":"0001914769","reported_name":"Smith Sean Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-04T16:41:34.000Z","date":"2022-08-02","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/4 of the total shares on August 2, 2023, and then 1/48 of the total shares will vest monthly thereafter, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":150000,"derivative":{"exercise_price":0.99,"expiration_date":"2032-08-01","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-22-044434","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1914769/000120919122044434/doc4.xml","form_type":"4"}},{"id":2355460,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":110573,"kind":"person","name":"Smith Sean Michael","position":1,"cik":"0001914769","reported_name":"Smith Sean Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-03T16:39:51.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the shares subject to the option will vest on March 2, 2023, and 1/48 of the shares subject to the option will vest monthly thereafter, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":80000,"derivative":{"exercise_price":2.72,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001209191-22-015479","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1914769/000120919122015479/doc4.xml","form_type":"4"}}]}